Imbalanced intestinal flora as predictive factor of response to infliximab in Crohn's disease

被引：0
|
作者：
Zhou, Youlian [1 ]
He, Yan [1 ]
Zhang, Ting [1 ]
Wang, Zhongqiu [1 ]
Zhang, Shaoheng [1 ]
Jiang, Bo [1 ]
Chen, Ye [1 ]
机构：
[1] Nanfang Hosp, Guangzhou, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
intestinal flora; Crohn's disease; Infliximab; predictive factor;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：805 / 805
页数：1
相关论文
共 50 条
  • [1] Predictive Value of Epithelial Gene Expression Profiles for Response to Infliximab in Crohn's Disease
    Arijs, Ingrid
    Quintens, Roel
    Van Lommel, Leentje
    Van Steen, Kristel
    De Hertogh, Gert
    Lemaire, Katleen
    Schraenen, Anica
    Perrier, Clementine
    Van Assche, Gert
    Vermeire, Severine
    Geboes, Karel
    Schuit, Frans
    Rutgeerts, Paul
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (12) : 2090 - 2098
  • [2] CD19+in intestinal mucosa predict the response to infliximab in Crohn's disease
    Ferkolj, I
    Ihan, A
    Markovic, S
    HEPATO-GASTROENTEROLOGY, 2005, 52 (64) : 1128 - 1133
  • [3] Response of cutaneous Crohn's disease to infliximab and methotrexate
    Konrad, A
    Seibold, F
    DIGESTIVE AND LIVER DISEASE, 2003, 35 (05) : 351 - 356
  • [4] Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease
    Bauer, Christina M.
    Younis, Adam
    Herfarth, Hans
    Barnes, Edward L.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (02) : E5 - E5
  • [5] Predictors of response to infliximab in patients with fistulizing Crohn's disease
    Luna-Chadid, M
    Calle, JLP
    Mendoza, JL
    Vera, MI
    Bermejo, AF
    Sánchez, F
    San Román, AL
    Froilán, C
    González-Lara, V
    García-Paredes, J
    Fernández-Blanco, I
    Abreu, L
    Casis, B
    Herruzo, JAS
    Gisbert, JP
    Maté-Jiménez, J
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2004, 96 (06) : 379 - 381
  • [6] Hidradenitis suppurativa and Crohn's disease:: Response to treatment with infliximab
    Martínez, F
    Nos, P
    Benlloch, S
    Ponce, J
    INFLAMMATORY BOWEL DISEASES, 2001, 7 (04) : 323 - 326
  • [7] Predictors of response to Infliximab in children with luminal Crohn's disease
    Grover, Zubin
    Biron, Rebecca
    Carman, Nicholas
    Lewindon, Peter
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (08) : 739 - 746
  • [8] Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn's Disease
    Alexdottir, Marta S.
    Bourgonje, Arno R.
    Karsdal, Morten A.
    Pehrsson, Martin
    Loveikyte, Roberta
    van Dullemen, Hendrik M.
    Visschedijk, Marijn C.
    Festen, Eleonora A. M.
    Weersma, Rinse K.
    Faber, Klaas Nico
    Dijkstra, Gerard
    Mortensen, Joachim H.
    FRONTIERS IN MEDICINE, 2022, 9
  • [9] Rapid response of severe refractory metastatic Crohn's disease to infliximab
    Miller, AM
    Elliott, PR
    Fink, R
    Connell, W
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (08) : 940 - 942
  • [10] Infliximab use in Crohn's disease
    Bewtra, M
    Lichtenstein, GR
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (04) : 589 - 599
12345